Press launch MHRA approves GLP –one receptor agonist semaglutide to lessen possibility of serious coronary heart difficulties in obese or overweight Older people Semaglutide is the 1st weightloss drug authorised in britain like a preventative therapy for anyone with set up cardiovascular diseaseBefore making use of Wegovy®, notify your Health ca… Read More